Novel ELISAs for Screening of the Biogenic Amines GABA, Glycine, β-Phenylethylamine, Agmatine, and Taurine Using One Derivatization Procedure of Whole Urine Samples
Novel ELISAs for Screening of the Biogenic Amines GABA, Glycine, β-Phenylethylamine, Agmatine, and Taurine Using One Derivatization Procedure of Whole Urine Samples
复制标题
DOI：
10.1021/ac100858u
复制
发表时间：
2010-08-01
影响因子：
7.4
通讯作者：
Kellermann, Gottfried
中科院分区：
文献类型：
--
作者：
Huisman, Han;Wynveen, Paul;Kellermann, Gottfried
The inhibitory neurotransmitters GABA, glycine and agmatine and neuromodulators beta-phenylethylamine (beta-PEA) and taurine are important biogenic amines of the sympathetic and parasympathetic nervous systems in the body. Abnormalities in the metabolism of these biomarkers have been implicated in a vast number of neurological diseases.Novel competitive immunoassays, using one unique whole urine derivatization procedure applicable for all five biomarkers, have been developed. The determination of these biomarkers was highly reproducible: the coefficient of variance of inter- and intra-assay variation is between 3.9% and 9.8% for all assays. The assays show a good linearity in urine samples within the range of 100-400 mg Cr/dL and specificity when urine samples are spiked with biogenic amines. The recoveries are between 76 and 154%. The correlation between HPLC and ELISA for glycine and taurine (n = 10) showed regression coefficients of 0.97 and 0.98, respectively.An in vivo study on the urinary clearance of beta-PEA, agmatine and taurine after oral intake by healthy individuals demonstrated the specificity and clinical significance of these new immunoassays. The immunoassays are useful for clinical and basic research where a fast and accurate assay for the screening of biogenic amines in urine is required, without preclearance of the sample.
